Radiotherapy of primary or recurrent bladder cancer in the very elderly

Stefan Janssen, Lisa Manig, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aim: The number of very elderly patients with cancer is growing and requires particular attention. The role of organ-sparing irradiation in patients with bladder cancer aged ≥80 years was investigated. Patients and Methods: In 29 very elderly (≥80 years) patients irradiated for bladder cancer, 12 characteristics were analysed for survival: indication, gender, age, Karnofsky performance score (KPS), T-/N-category, tumour grade, pack years, smoking during irradiation, radiation dose, interruption of irradiation >5 days and concurrent chemotherapy. Results: On univariate analysis, primary treatment (p=0.001), KPS >70 (p=0.026) and not smoking during radiotherapy (p<0.001) were associated with better survival. A strong trend for such association was observed for female gender (p=0.054), <40 pack years (p=0.064) and concurrent chemotherapy (p=0.061), and a trend for no interruption of irradiation (p=0.09). On multivariate analysis, primary treatment (p=0.006) and not smoking during radiotherapy (p=0.038) maintained significance. Conclusion: Very elderly patients irradiated for bladder cancer may benefit from concurrent chemotherapy. Smoking during irradiation and interruptions of irradiation should be avoided.

Original languageEnglish (US)
Pages (from-to)3287-3290
Number of pages4
JournalAnticancer Research
Volume37
Issue number6
DOIs
StatePublished - Jun 1 2017

Fingerprint

Urinary Bladder Neoplasms
Radiotherapy
Smoking
Drug Therapy
Survival
Neoplasms
Multivariate Analysis
Radiation
Therapeutics

Keywords

  • Bladder cancer
  • Organ preservation
  • Radio-chemotherapy
  • Radiotherapy
  • Very elderly patients

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Radiotherapy of primary or recurrent bladder cancer in the very elderly. / Janssen, Stefan; Manig, Lisa; Schild, Steven E.; Rades, Dirk.

In: Anticancer Research, Vol. 37, No. 6, 01.06.2017, p. 3287-3290.

Research output: Contribution to journalArticle

Janssen, Stefan ; Manig, Lisa ; Schild, Steven E. ; Rades, Dirk. / Radiotherapy of primary or recurrent bladder cancer in the very elderly. In: Anticancer Research. 2017 ; Vol. 37, No. 6. pp. 3287-3290.
@article{c5c2010a23fb4c458d20c3155a7788ed,
title = "Radiotherapy of primary or recurrent bladder cancer in the very elderly",
abstract = "Aim: The number of very elderly patients with cancer is growing and requires particular attention. The role of organ-sparing irradiation in patients with bladder cancer aged ≥80 years was investigated. Patients and Methods: In 29 very elderly (≥80 years) patients irradiated for bladder cancer, 12 characteristics were analysed for survival: indication, gender, age, Karnofsky performance score (KPS), T-/N-category, tumour grade, pack years, smoking during irradiation, radiation dose, interruption of irradiation >5 days and concurrent chemotherapy. Results: On univariate analysis, primary treatment (p=0.001), KPS >70 (p=0.026) and not smoking during radiotherapy (p<0.001) were associated with better survival. A strong trend for such association was observed for female gender (p=0.054), <40 pack years (p=0.064) and concurrent chemotherapy (p=0.061), and a trend for no interruption of irradiation (p=0.09). On multivariate analysis, primary treatment (p=0.006) and not smoking during radiotherapy (p=0.038) maintained significance. Conclusion: Very elderly patients irradiated for bladder cancer may benefit from concurrent chemotherapy. Smoking during irradiation and interruptions of irradiation should be avoided.",
keywords = "Bladder cancer, Organ preservation, Radio-chemotherapy, Radiotherapy, Very elderly patients",
author = "Stefan Janssen and Lisa Manig and Schild, {Steven E.} and Dirk Rades",
year = "2017",
month = "6",
day = "1",
doi = "10.21873/anticanres.11694",
language = "English (US)",
volume = "37",
pages = "3287--3290",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Radiotherapy of primary or recurrent bladder cancer in the very elderly

AU - Janssen, Stefan

AU - Manig, Lisa

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Aim: The number of very elderly patients with cancer is growing and requires particular attention. The role of organ-sparing irradiation in patients with bladder cancer aged ≥80 years was investigated. Patients and Methods: In 29 very elderly (≥80 years) patients irradiated for bladder cancer, 12 characteristics were analysed for survival: indication, gender, age, Karnofsky performance score (KPS), T-/N-category, tumour grade, pack years, smoking during irradiation, radiation dose, interruption of irradiation >5 days and concurrent chemotherapy. Results: On univariate analysis, primary treatment (p=0.001), KPS >70 (p=0.026) and not smoking during radiotherapy (p<0.001) were associated with better survival. A strong trend for such association was observed for female gender (p=0.054), <40 pack years (p=0.064) and concurrent chemotherapy (p=0.061), and a trend for no interruption of irradiation (p=0.09). On multivariate analysis, primary treatment (p=0.006) and not smoking during radiotherapy (p=0.038) maintained significance. Conclusion: Very elderly patients irradiated for bladder cancer may benefit from concurrent chemotherapy. Smoking during irradiation and interruptions of irradiation should be avoided.

AB - Aim: The number of very elderly patients with cancer is growing and requires particular attention. The role of organ-sparing irradiation in patients with bladder cancer aged ≥80 years was investigated. Patients and Methods: In 29 very elderly (≥80 years) patients irradiated for bladder cancer, 12 characteristics were analysed for survival: indication, gender, age, Karnofsky performance score (KPS), T-/N-category, tumour grade, pack years, smoking during irradiation, radiation dose, interruption of irradiation >5 days and concurrent chemotherapy. Results: On univariate analysis, primary treatment (p=0.001), KPS >70 (p=0.026) and not smoking during radiotherapy (p<0.001) were associated with better survival. A strong trend for such association was observed for female gender (p=0.054), <40 pack years (p=0.064) and concurrent chemotherapy (p=0.061), and a trend for no interruption of irradiation (p=0.09). On multivariate analysis, primary treatment (p=0.006) and not smoking during radiotherapy (p=0.038) maintained significance. Conclusion: Very elderly patients irradiated for bladder cancer may benefit from concurrent chemotherapy. Smoking during irradiation and interruptions of irradiation should be avoided.

KW - Bladder cancer

KW - Organ preservation

KW - Radio-chemotherapy

KW - Radiotherapy

KW - Very elderly patients

UR - http://www.scopus.com/inward/record.url?scp=85019739870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019739870&partnerID=8YFLogxK

U2 - 10.21873/anticanres.11694

DO - 10.21873/anticanres.11694

M3 - Article

C2 - 28551678

AN - SCOPUS:85019739870

VL - 37

SP - 3287

EP - 3290

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -